Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,79 USD | -0,62% | +1,10% | +13,81% |
14/03 | ANIKA THERAPEUTICS, INC. : Barrington Research herhaalt koopadvies | ZM |
13/03 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Omzet 2024 * | 170 mln. 159 mln. | Omzet 2025 * | 182 mln. 170 mln. | Marktkapitalisatie | 378 mln. 354 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -2 mln. -1,87 mln. | Nettowinst (verlies) 2025 * | 6 mln. 5,61 mln. | EV/omzet 2024 * | 2,22 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,08 x |
K/w-verhouding 2024 * |
-168
x | K/w-verhouding 2025 * |
62,4
x | Werknemers | 357 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,4% |
Recentste transcriptie over Anika Therapeutics, Inc.
1 dag | -0,62% | ||
1 week | +1,10% | ||
Lopende maand | +1,54% | ||
1 maand | +1,30% | ||
3 maanden | +12,62% | ||
6 maanden | +38,66% | ||
Lopend jaar | +13,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31-08-18 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 10-08-20 |
Anne Nunes
COO | Chief Operating Officer | 55 | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 23-10-18 |
Sheryl Conley
BRD | Director/Board Member | 63 | 28-10-21 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31-08-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.32% | 27 M€ | -4,16% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 25,79 | -0,62% | 35 868 |
22-04-24 | 25,95 | +0,43% | 37 540 |
19-04-24 | 25,84 | +1,61% | 49 278 |
18-04-24 | 25,43 | -1,01% | 83 322 |
17-04-24 | 25,69 | +0,71% | 53 028 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,81% | 378 mln. | |
-2,86% | 87,37 mld. | |
+4,08% | 41,01 mld. | |
-25,35% | 28,08 mld. | |
+53,87% | 24,72 mld. | |
-4,52% | 17,47 mld. | |
-42,09% | 11,69 mld. | |
-17,77% | 11,6 mld. | |
-12,10% | 11,56 mld. | |
+1,35% | 8,44 mld. |